Back to search

Japan· JP-2646700M1163

ジフルコルトロン吉草酸エステル

A diflucortolone product containing ジフルコルトロン吉草酸エステル, registered in Japan by レオファーマ, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

On Japan’s NHI price listATC D07AC06

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedジフルコルトロン吉草酸エステルATCD07AC06REGISTER NO.JP-2646700M1163PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Diflucortolone is registered in 4 of 19 countries.

Countries holding a registration under ATC D07AC06 (diflucortolone), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 3 of them publish a price we can compare per daily dose

Diflucortolone · ATC D07AC06

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Italyprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ジフルコルトロン吉草酸エステル
Manufacturer
レオファーマ
Country
Japan (JP)
ATC code
D07AC06
ATC class
Diflucortolone
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diflucortolone in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diflucortolone products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Neriforte, Nerisona
  • Germany · Nerisona
  • Spain · Claral
  • France · Nerisone, Nerisone Gras
  • Italy · Dermaval, Dervin
  • Portugal · Nerisona

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce02cf4c-a1d9-4e39-b06c-0f14bf80cff7
GET /v1/drugs/ce02cf4c-a1d9-4e39-b06c-0f14bf80cff7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.1%1g",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2646700M1163",
  "category": "外用薬",
  "price_yen": 15.9,
  "generic_name": "ジフルコルトロン吉草酸エステル",
  "product_name_jp": null,
  "therapeutic_class": "2646",
  "transitional_expiry": null
}

See everything about diflucortolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.